GLP-1 receptor agonist
3-[(1S,2S)-1-[2-[(4S)-7,7-difluoro-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-[4-fluoro-1-(trifluoromethyl)indazol-5-yl]-2-oxoimidazol-1-yl]-4-methyl-4,6-dihydropyrazolo[4,3-c]pyridine-5-carbonyl]-5-[(4S)-2,2-dimethyloxan-4-yl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one
Molecular Identity
GLP-1 receptor agonist
3-[(1S,2S)-1-[2-[(4S)-7,7-difluoro-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-[4-fluoro-1-(trifluoromethyl)indazol-5-yl]-2-oxoimidazol-1-yl]-4-methyl-4,6-dihydropyrazolo[4,3-c]pyridine-5-carbonyl]-5-[(4S)-2,2-dimethyloxan-4-yl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one
PubChem CID: 177864544
2D Structure
Properties
C48H43F7N10O5
Molecular Formula
972.90
Molecular Weight
g/mol
972.3306
Exact Mass
Da
8.1
XLogP
Above Lipinski threshold
144
TPSA
May have limited oral absorption
1
H-Bond Donors
15
H-Bond Acceptors
2140
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(3)
GLP-1 receptor agonistEX-A164523103539-71-2
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to GLP-1 receptor agonist
Loading drug network...